{
  "publication": {
    "pmc_id": "PMC8890767",
    "title": "Safety and Pharmacokinetics of Intranasally Administered Heparin",
    "year": "2022",
    "journal": "Pharma Res."
  },
  "authors": [
    "Harris, Hannah M.",
    "Boyet, Katherine L.",
    "Liu, Hao",
    "Dwivedi, Rohini",
    "Ashpole, Nicole M.",
    "Tandon, Ritesh",
    "Bidwell III, Gene L.",
    "Cheng, Zhi",
    "Fassero, Lauren A.",
    "Yu, Christian S.",
    "Pomin, Vitor H.",
    "Mitra, Dipanwita",
    "Harrison, Kerri A.",
    "Dahl, Eric",
    "Gurley, Bill J.",
    "Kotha, Arun Kumar",
    "Chougule, Mahavir Bhupal",
    "Sharp, Joshua S."
  ],
  "subjects": {
    "species": [
      "C57Bl6 mouse",
      "human subject"
    ],
    "tissues": [
      "nasal cavity",
      "lung",
      "intestinal"
    ]
  },
  "methods": {
    "platforms": [
      "in vivo imaging",
      "blood coagulation measurements"
    ],
    "assays": [
      "activated partial thromboplastin time (aPTT)",
      "platelet count",
      "international normalized ratio (INR)"
    ]
  },
  "treatments": [
    {
      "agent": "UFH",
      "dose": {
        "amount": "60\u00a0ng to 60\u00a0\u03bcg",
        "unit": "ng to \u03bcg"
      },
      "duration": "14 days"
    }
  ],
  "results": [
    {
      "target": "aPTT",
      "effect": "no significant changes",
      "magnitude": null
    },
    {
      "target": "INR",
      "effect": "no significant changes",
      "magnitude": null
    },
    {
      "target": "platelet count",
      "effect": "no significant changes",
      "magnitude": null
    }
  ]
}